Back to ENTA
FARALLON CAPITAL MANAGEMENT, L.L.C. → ENTA
FARALLON CAPITAL MANAGEMENT, L.L.C. ENTA Position History
Enanta Pharmaceuticals, Inc. • Healthcare
Quarters held
15
Latest value
$35.3M
Q2 2026
Peak value
$43.7M
First seen
Q2 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2023 | $40.1M |
| Q3 2023 | $20.9M |
| Q4 2023 | $19.1M |
| Q1 2024 | $36.6M |
| Q1 2024 | $36.6M |
| Q2 2024 | $27.2M |
| Q3 2024 | $21.8M |
| Q4 2024 | $12.1M |
| Q1 2025 | $11.7M |
| Q2 2025 | $16M |
| Q3 2025 | $25.4M |
| Q3 2025 | $25.4M |
| Q4 2025 | $43.7M |
| Q1 2026 | $36.3M |
| Q2 2026 | $35.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $35.3M | 2.42M | — | — |
| Q1 2026 | $36.3M | 2.87M | — | — |
| Q4 2025 | $43.7M | 2.77M | — | — |
| Q3 2025 | $25.4M | 2.12M | — | — |
| Q3 2025 | $25.4M | 2.12M | — | — |
| Q2 2025 | $16M | 2.12M | — | — |
| Q1 2025 | $11.7M | 2.12M | — | — |
| Q4 2024 | $12.1M | 2.11M | — | — |
| Q3 2024 | $21.8M | 2.11M | — | — |
| Q2 2024 | $27.2M | 2.10M | — | — |
| Q1 2024 | $36.6M | 2.10M | — | — |
| Q1 2024 | $36.6M | 2.10M | — | — |
| Q4 2023 | $19.1M | 2.02M | — | — |
| Q3 2023 | $20.9M | 1.88M | — | — |
| Q2 2023 | $40.1M | 1.88M | — | — |